These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

140 related articles for article (PubMed ID: 17435342)

  • 1. [Pharmacological properties and clinical efficacy of entecavir monohydrate (Baraclude Tablet 0.5 mg), an anti-HBV drug].
    Amano M; Goto A
    Nihon Yakurigaku Zasshi; 2007 Apr; 129(4):287-97. PubMed ID: 17435342
    [No Abstract]   [Full Text] [Related]  

  • 2. Chinese herbal extract Su-duxing had potent inhibitory effects on both wild-type and entecavir-resistant hepatitis B virus (HBV) in vitro and effectively suppressed HBV replication in mouse model.
    Liu Y; Yao W; Si L; Hou J; Wang J; Xu Z; Li W; Chen J; Li R; Li P; Bo L; Xiao X; Lan J; Xu D
    Antiviral Res; 2018 Jul; 155():39-47. PubMed ID: 29702120
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Entecavir (Bristol-Myers Squibb).
    Billich A
    Curr Opin Investig Drugs; 2001 May; 2(5):617-21. PubMed ID: 11569933
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Entecavir allows an unexpectedly high residual replication of HBV mutants resistant to lamivudine.
    Geipel A; Seiz PL; Niekamp H; Neumann-Fraune M; Zhang K; Kaiser R; Protzer U; Gerlich WH; Glebe D;
    Antivir Ther; 2015; 20(8):779-87. PubMed ID: 25560463
    [TBL] [Abstract][Full Text] [Related]  

  • 5. [Entecavir therapy against hepatitis B].
    Kato N; Omata M
    Nihon Rinsho; 2004 Aug; 62 Suppl 8():340-4. PubMed ID: 15453342
    [No Abstract]   [Full Text] [Related]  

  • 6. Resistance of hepatitis B virus to antiviral drugs: current aspects and directions for future investigation.
    Delaney WE; Locarnini S; Shaw T
    Antivir Chem Chemother; 2001 Jan; 12(1):1-35. PubMed ID: 11437320
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [New advances in the treatment of chronic hepatitis B: position of entecavir].
    Olaso V
    Rev Esp Quimioter; 2007 Sep; 20(3):259-60. PubMed ID: 18080023
    [No Abstract]   [Full Text] [Related]  

  • 8. Entecavir is a potent anti-HBV drug superior to lamivudine: experience from clinical trials in China.
    Yao G
    J Antimicrob Chemother; 2007 Aug; 60(2):201-5. PubMed ID: 17556353
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Efficacy of NVR 3-778, Alone and In Combination With Pegylated Interferon, vs Entecavir In uPA/SCID Mice With Humanized Livers and HBV Infection.
    Klumpp K; Shimada T; Allweiss L; Volz T; Lütgehetmann M; Hartman G; Flores OA; Lam AM; Dandri M
    Gastroenterology; 2018 Feb; 154(3):652-662.e8. PubMed ID: 29079518
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [Entecavir - options and obstacles of an effective treatment for chronic hepatitis B].
    Cornberg M; Manns MP
    Dtsch Med Wochenschr; 2010 Jan; 135(1-2):32-7. PubMed ID: 20024882
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Analysis of HBV genotype, drug resistant mutations, and pre-core/basal core promoter mutations in Korean patients with acute hepatitis B.
    Lee JH; Hong SP; Jang ES; Park SJ; Hwang SG; Kang SK; Jeong SH
    J Med Virol; 2015 Jun; 87(6):993-8. PubMed ID: 25712861
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Five-year data released for entecavir.
    AIDS Patient Care STDS; 2008 Apr; 22(4):349. PubMed ID: 18422464
    [No Abstract]   [Full Text] [Related]  

  • 13. [Anti-hepatitis B virus drugs].
    Minami M
    Nihon Rinsho; 2012 Apr; 70(4):609-13. PubMed ID: 22568141
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Two-year assessment of entecavir resistance in Lamivudine-refractory hepatitis B virus patients reveals different clinical outcomes depending on the resistance substitutions present.
    Tenney DJ; Rose RE; Baldick CJ; Levine SM; Pokornowski KA; Walsh AW; Fang J; Yu CF; Zhang S; Mazzucco CE; Eggers B; Hsu M; Plym MJ; Poundstone P; Yang J; Colonno RJ
    Antimicrob Agents Chemother; 2007 Mar; 51(3):902-11. PubMed ID: 17178796
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Entecavir.
    Opio CK; Lee WM; Kirkpatrick P
    Nat Rev Drug Discov; 2005 Jul; 4(7):535-6. PubMed ID: 16075486
    [No Abstract]   [Full Text] [Related]  

  • 16. Advances in the treatment of hepatitis B virus/hepatitis C virus coinfection.
    Sagnelli E; Pisaturo M; Martini S; Sagnelli C; Filippini P; Coppola N
    Expert Opin Pharmacother; 2014 Jul; 15(10):1337-49. PubMed ID: 24773464
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Hepatitis B-associated acute liver failure: immediate treatment with entecavir inhibits hepatitis B virus replication and potentially its sequelae.
    Jochum C; Gieseler RK; Gawlista I; Fiedler A; Manka P; Saner FH; Roggendorf M; Gerken G; Canbay A
    Digestion; 2009; 80(4):235-40. PubMed ID: 19828954
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Entecavir: a potent new antiviral drug for hepatitis B.
    Honkoop P; De Man RA
    Expert Opin Investig Drugs; 2003 Apr; 12(4):683-8. PubMed ID: 12665423
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [Evolution of hepatitis B virus quasispecies during lamivudine-entecavir sequential therapy].
    Liu L; Tang YZ; Li JG; Zhou JJ; Wang XH; Wang YM
    Zhonghua Gan Zang Bing Za Zhi; 2010 Jun; 18(6):423-7. PubMed ID: 20587311
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Molecular characterization of a novel entecavir mutation pattern isolated from a multi-drug refractory patient with chronic hepatitis B infection.
    Karatayli E; Karatayli SC; Cinar K; Gokahmetoglu S; Güven K; Idilman R; Yurdaydin C; Bozdayi AM
    J Clin Virol; 2012 Feb; 53(2):130-4. PubMed ID: 22078148
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.